Literature DB >> 27473931

Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry.

Rong Ni1, Junli Zhou2, Naushad Hossain3, Ying Chau4.   

Abstract

Targeted delivery of nucleic acids into disease sites of human body has been attempted for decades, but both viral and non-viral vectors are yet to meet our expectations. Safety concerns and low delivery efficiency are the main limitations of viral and non-viral vectors, respectively. The structure of viruses is both ordered and dynamic, and is believed to be the key for effective transfection. Detailed understanding of the physical properties of viruses, their interaction with cellular components, and responses towards cellular environments leading to transfection would inspire the development of safe and effective non-viral vectors. To this goal, this review systematically summarizes distinctive features of viruses that are implied for efficient nucleic acid delivery but not yet fully explored in current non-viral vectors. The assembly and disassembly of viral structures, presentation of viral ligands, and the subcellular targeting of viruses are emphasized. Moreover, we describe the current development of cationic material-based viral mimicry (CVM) and structural viral mimicry (SVM) in these aspects. In light of the discrepancy, we identify future opportunities for rational design of viral mimics for the efficient delivery of DNA and RNA.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bionanotechnology; Gene therapy; Nanocarrier; Non-viral vector; Self-assembly peptide; Viral mimicry

Mesh:

Substances:

Year:  2016        PMID: 27473931     DOI: 10.1016/j.addr.2016.07.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  14 in total

1.  Design of a Lentiviral Vector for the Inducible Expression of MYC: A New Strategy for Construction Approach.

Authors:  Onur Tokgun; Francesco Paolo Fiorentino; Pervin Elvan Tokgun; Jun Yokota; Hakan Akca
Journal:  Mol Biotechnol       Date:  2017-06       Impact factor: 2.695

Review 2.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

3.  Production and Use of Gesicles for Nucleic Acid Delivery.

Authors:  Mathias Mangion; Marc-André Robert; Igor Slivac; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2021-10-01       Impact factor: 2.695

Review 4.  Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.

Authors:  Michael F Naso; Brian Tomkowicz; William L Perry; William R Strohl
Journal:  BioDrugs       Date:  2017-08       Impact factor: 5.807

5.  Reducible PEG-POD/DNA Nanoparticles for Gene Transfer In Vitro and In Vivo: Application in a Mouse Model of Age-Related Macular Degeneration.

Authors:  Bhanu Chandar Dasari; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-10       Impact factor: 8.886

6.  Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex.

Authors:  Xiang Wang; Yuanqi Hua; Guangya Xu; Senyi Deng; Daoke Yang; Xiang Gao
Journal:  Int J Nanomedicine       Date:  2019-04-15

Review 7.  Biomaterial-based delivery systems of nucleic acid for regenerative research and regenerative therapy.

Authors:  Jun-Ichiro Jo; Jian-Qing Gao; Yasuhiko Tabata
Journal:  Regen Ther       Date:  2019-07-11       Impact factor: 3.419

8.  A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells.

Authors:  Jingen Zhu; Pan Tao; Marthandan Mahalingam; Jian Sha; Paul Kilgore; Ashok K Chopra; Venigalla Rao
Journal:  Sci Adv       Date:  2019-08-21       Impact factor: 14.136

Review 9.  Emerging Concepts and Challenges in Rheumatoid Arthritis Gene Therapy.

Authors:  Andrei A Deviatkin; Yulia A Vakulenko; Ludmila V Akhmadishina; Vadim V Tarasov; Marina I Beloukhova; Andrey A Zamyatnin; Alexander N Lukashev
Journal:  Biomedicines       Date:  2020-01-09

10.  Isolated cell-bound membrane vesicles (CBMVs) as a novel class of drug nanocarriers.

Authors:  Yang Zhang; Yang Liu; Wendiao Zhang; Qisheng Tang; Yun Zhou; Yuanfang Li; Tong Rong; Huaying Wang; Yong Chen
Journal:  J Nanobiotechnology       Date:  2020-05-06       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.